Generation Bio ROE 2020-2023 | GBIO
Current and historical return on equity (ROE) values for Generation Bio (GBIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Generation Bio ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$-0.13B |
$0.20B |
-52.07% |
| 2023-09-30 |
$-0.12B |
$0.23B |
-46.99% |
| 2023-06-30 |
$-0.13B |
$0.25B |
-44.84% |
| 2023-03-31 |
$-0.13B |
$0.28B |
-44.52% |
| 2022-12-31 |
$-0.14B |
$0.28B |
-42.87% |
| 2022-09-30 |
$-0.14B |
$0.31B |
-39.44% |
| 2022-06-30 |
$-0.14B |
$0.33B |
-37.08% |
| 2022-03-31 |
$-0.13B |
$0.35B |
-32.76% |
| 2021-12-31 |
$-0.12B |
$0.38B |
-28.55% |
| 2021-09-30 |
$-0.11B |
$0.41B |
-28.84% |
| 2021-06-30 |
$-0.10B |
$0.43B |
-28.20% |
| 2021-03-31 |
$-0.09B |
$0.46B |
-27.01% |
| 2020-12-31 |
$-0.08B |
$0.27B |
-37.72% |
| 2020-06-30 |
$-0.05B |
$0.30B |
-68.42% |
| 2020-03-31 |
$-0.05B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.200B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
